|
Search |
This is not a consumer level recall and the risk of any adverse health effects related to the to the reason for the recall is unlikely.
Johnson & Johnson's McNeil Consumer Healthcare is voluntarily recalling, at the retail and wholesale level, certain lots of products containing Tylenol Cold-Multi Symptom Nighttime Rapid Release Gelcaps distributed in the U.S.
The company has recalled dozens of other products over the last year for the same "musty odor." The recalled product was manufactured in February, 2009.
The voluntary recall was due to a "a small number of odor reports," the company's McNeil Consumer Healthcare unit state in a statement.
While the risk of any serious medical problems is remote, the odor has been linked to a chemical that can cause "temporary and non-serious gas
Johnson & Johnson (NYSE:JNJ) announced late yesterday that the company is recalling more than 60,000 bottles of extra strength caplets because of a musty odor.
The charge is related to restructuring plans by its subsidiary, the Cordis Corporation.
Johnson & Johnson (NYSE:JNJ) announced today that it expects to record an after-tax restructuring charge in the second quarter in the range of $500 to $600 million.
The US Court of Appeals for the Washington Federal Circuit upheld the 2009 jury verdict that favored privately-held Spectralytics.
J&J shares are up 0.94%, or $0.62, to $66.71.
Shares of Johnson & Johnson (NYSE:JNJ) are holding gains despite a Bloomberg report that the Cordis unit of the health care products maker lost its appeal of a $22.4 million patent-infringment verdict.
According to the story, a J&J subsidiary has been under investigation since 2004 over whether the drug Risperdal has been improperly promoted for unapproved uses.
Federal prosecutors are said to be seeking about $1 billion to resolve a long-running inquiry into Johnson & Johnson's (JNJ) marketing of an antipsychotic drug, according to the Wall Street Journal.
Recalls at Johnson & Johnson(JNJ) mean big profit for Novartis (NVS). According to Chief Financial Officer Jon Symonds, he said the company's is benefitting in the consumer drug division and Novartis is reportedly interested
 |
Shares of Zimmer (NYSE:ZMH) traded today at $81.72, breaking its 52-week high. This ne ...
 |
Shares of Yingli Green Energy (NYSE:YGE) traded at a new 52-week high today of $4.83. ...
 |
Shares of Crosstex Energy (NASDAQ:XTEX) traded today at $21.15, breaking its 52-week hi ...
 |
Shares of Washington Real Estate Investment Trust (NYSE:WRE) traded at a new 52-week hi ...
 |
Weatherford International (NYSE:WFT) traded today at a new 52-week high of $14.46. Thi ...
 |
Waste Connections (NYSE:WCN) traded today at a new 52-week high of $40.70. So far toda ...
 |
Shares of USANA Health Sciences (NYSE:USNA) traded at a new 52-week high today of $68.9 ...
 |
Umpqua Holdings (NASDAQ:UMPQ) traded today at a new 52-week high of $13.91. Approximat ...
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up
its...
The Wall Street Journal reports that home prices showed their best year-to-date gains since 2005, up 5.9% through July, signaling the housing market's steady march toward recovery. Also from the Wall Street Journal, IBM (IBM) will increase its efforts to sell so-called cloud computing services...
CEO Marissa Mayer is bringing in some more new blood to Yahoo!, tapping Ken Goldman as the company's new Chief Financial Officer. Goldman's appointment will take effect on October 22nd.
Goldman served as CFO at his most recent employer, Fortinet, having worked at Siebel Systems, Sybase,...
